{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:15:08Z","timestamp":1785762908392,"version":"3.56.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Fundaci\u00f3n Luz\u00f3n"},{"DOI":"10.13039\/501100018676","name":"Victorian Brain Bank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018676","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Alfred, Victorian Institute of Forensic Medicine"},{"name":"Coroners Court of Victoria"},{"DOI":"10.13039\/100009685","name":"Parkinson\u2019s Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009685","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014012","name":"FightMND","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016005","name":"Yulgilbar Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ian and Maria Cootes"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Metabolic changes are observed in patients with both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Although regulation of metabolic processes in the CNS is predominantly carried out within the hypothalamus, extra-hypothalamic CNS areas contain metabolic hormone receptors, including those for leptin (LEPR), insulin (INSR), and neuropeptide Y (NPY), indicating that they may play a role in biological processes underlying pathogenic disease processes. The status of these hormones within regions vulnerable in ALS\/FTD is not well described. This study sought to determine whether the expression of these hormones and their receptors is altered in pathology-rich regions in cases of human FTD (superior frontal gyrus and insular cortex) and ALS (primary motor cortex and lumbar spinal cord) with TDP-43 pathology compared to matched healthy controls. LEPR mRNA was increased within the superior frontal gyrus of FTD cases and within primary motor cortex and lumbar spinal cord of ALS cases; INSR mRNA was increased in superior frontal gyrus and insular cortex of FTD cases. NPY protein was decreased in primary motor cortex and lumbar spinal cord of ALS cases. Our results demonstrate that metabolic hormones undergo complex alterations in ALS and FTD and suggest that these hormones could play critical roles in the pathogenesis of these diseases.<\/jats:p>","DOI":"10.1093\/jnen\/nlae054","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T21:17:08Z","timestamp":1719350228000},"page":"907-916","source":"Crossref","is-referenced-by-count":6,"title":["Alterations to metabolic hormones in amyotrophic lateral sclerosis and frontotemporal dementia postmortem human tissue"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9846-7738","authenticated-orcid":false,"given":"Rachel A K","family":"Atkinson","sequence":"first","affiliation":[{"name":"Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania , Hobart, Tasmania,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M","family":"Collins","sequence":"additional","affiliation":[{"name":"Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania , Hobart, Tasmania,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemeen","family":"Sreedharan","sequence":"additional","affiliation":[{"name":"Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E","family":"King","sequence":"additional","affiliation":[{"name":"Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania , Hobart, Tasmania,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen M","family":"Fernandez-Martos","sequence":"additional","affiliation":[{"name":"Wicking Dementia Research and Education Centre, College of Health and Medicine, University of Tasmania , Hobart, Tasmania,","place":["Australia"]},{"name":"Department of Health and Pharmaceutical Sciences, School of Pharmacy, Universidad CEU-San Pablo, CEU Universities , Madrid,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"issue":"5","key":"2024101807511943900_nlae054-B1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/CPJ.0000000000000521","article-title":"Body mass index and survival from amyotrophic lateral sclerosis: a meta-analysis","volume":"8","author":"Dardiotis","year":"2018","journal-title":"Neurol Clin Pract"},{"issue":"13","key":"2024101807511943900_nlae054-B2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia is a protective factor in amyotrophic lateral sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"2024101807511943900_nlae054-B3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","article-title":"Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis","volume":"258","author":"Dorst","year":"2011","journal-title":"J Neurol"},{"issue":"5","key":"2024101807511943900_nlae054-B4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1468-1331.2009.02923.x","article-title":"ALS disease onset may occur later in patients with pre-morbid diabetes mellitus","volume":"17","author":"Jawaid","year":"2010","journal-title":"Eur J Neurol"},{"issue":"2","key":"2024101807511943900_nlae054-B5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.25661","article-title":"Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis","volume":"87","author":"Ludolph","year":"2020","journal-title":"Ann Neurol"},{"issue":"4","key":"2024101807511943900_nlae054-B6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrneurol.2010.18","article-title":"TAR DNA-binding protein 43 in neurodegenerative disease","volume":"6","author":"Chen-Plotkin","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2024101807511943900_nlae054-B7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1474-4422(15)00380-4","article-title":"Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism","volume":"15","author":"Ahmed","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"2024101807511943900_nlae054-B8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fnmol.2018.00002","article-title":"Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism","volume":"11","author":"Vercruysse","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2024101807511943900_nlae054-B9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/brain\/aww263","article-title":"Energy expenditure in frontotemporal dementia: a behavioural and imaging study","volume":"140","author":"Ahmed","year":"2017","journal-title":"Brain"},{"issue":"8","key":"2024101807511943900_nlae054-B10","doi-asserted-by":"crossref","first-page":"e71793","DOI":"10.1371\/journal.pone.0071793","article-title":"TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis","volume":"8","author":"Stallings","year":"2013","journal-title":"PLoS One"},{"issue":"37","key":"2024101807511943900_nlae054-B11","doi-asserted-by":"crossref","first-page":"16320","DOI":"10.1073\/pnas.1002176107","article-title":"Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism","volume":"107","author":"Chiang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"51","key":"2024101807511943900_nlae054-B12","doi-asserted-by":"crossref","first-page":"32686","DOI":"10.1074\/jbc.272.51.32686","article-title":"Divergent signaling capacities of the long and short isoforms of the leptin receptor","volume":"272","author":"Bj\u00f8rb\u00e6k","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"2024101807511943900_nlae054-B13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/me.2015-1232","article-title":"Minireview: CNS mechanisms of leptin action","volume":"30","author":"Flak","year":"2016","journal-title":"Mol Endocrinol"},{"key":"2024101807511943900_nlae054-B14","doi-asserted-by":"crossref","first-page":"340)","DOI":"10.3389\/fncel.2018.00340","article-title":"Regulation of hippocampal synaptic function by the metabolic hormone, leptin: implications for health and neurodegenerative disease","volume":"12","author":"McGregor","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"2024101807511943900_nlae054-B15","doi-asserted-by":"crossref","first-page":"378)","DOI":"10.3389\/fnins.2019.00378","article-title":"Role of leptin in mood disorder and neurodegenerative disease","volume":"13","author":"Zou","year":"2019","journal-title":"Front Neurosci"},{"issue":"Pt B","key":"2024101807511943900_nlae054-B16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2017.12.025","article-title":"Leptin and ghrelin: sewing metabolism onto neurodegeneration","volume":"136","author":"de Candia","year":"2018","journal-title":"Neuropharmacology"},{"key":"2024101807511943900_nlae054-B17","doi-asserted-by":"crossref","first-page":"138):1-7","DOI":"10.3389\/fendo.2016.00138","article-title":"Possible integrative actions of leptin and insulin signaling in the hypothalamus targeting energy homeostasis","volume":"7","author":"Thon","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024101807511943900_nlae054-B18","doi-asserted-by":"crossref","first-page":"695623","DOI":"10.3389\/fcell.2021.695623","article-title":"Neuropeptide Y and metabolism syndrome: an update on perspectives of clinical therapeutic intervention strategies","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2024101807511943900_nlae054-B19","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.2174\/0929867329666220216113517","article-title":"Glycogen synthase kinase 3\u03b2 involvement in neuroinflammation and neurodegenerative diseases","volume":"29","author":"Gianferrara","year":"2022","journal-title":"Curr Med Chem"},{"issue":"18","key":"2024101807511943900_nlae054-B20","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1074\/jbc.M508691200","article-title":"Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3\u03b2","volume":"281","author":"Valerio","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"2024101807511943900_nlae054-B21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2009.03.066","article-title":"Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells","volume":"455","author":"Greco","year":"2009","journal-title":"Neurosci Lett"},{"issue":"3","key":"2024101807511943900_nlae054-B22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/acn3.721","article-title":"Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"6","author":"Ahmed","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"2024101807511943900_nlae054-B23","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1038\/s41598-017-04706-5","article-title":"Adipokines, C-reactive protein and amyotrophic lateral sclerosis \u2013 results from a population-based ALS registry in Germany","volume":"7","author":"Nagel","year":"2017","journal-title":"Sci Rep"},{"key":"2024101807511943900_nlae054-B24","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.3390\/ijms24065065","article-title":"Distinct plasma immune profile in ALS implicates sTNFR-II in pAMPK\/leptin homeostasis","volume":"24","author":"Picher-Martel","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2024101807511943900_nlae054-B25","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.3390\/ijms221910305","article-title":"Alterations in leptin signaling in amyotrophic lateral sclerosis (ALS)","volume":"22","author":"Ferrer-Donato","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"Suppl 15","key":"2024101807511943900_nlae054-B26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1212\/WNL.96.15_supplement.1276","article-title":"Changes in leptin, CCL16 and sTNF-RII as a distinctive plasma immune profile in patients with fast progressing ALS (1276)","volume":"96","author":"Picher-Martel","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"2024101807511943900_nlae054-B27","doi-asserted-by":"crossref","first-page":"e21707","DOI":"10.1096\/fj.202002450R","article-title":"Glucose clearance and uptake is increased in the SOD1G93A mouse model of amyotrophic lateral sclerosis through an insulin-independent mechanism","volume":"35","author":"McDonald","year":"2021","journal-title":"FASEB J"},{"issue":"3","key":"2024101807511943900_nlae054-B28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/jnc.15125","article-title":"Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis","volume":"156","author":"Clark","year":"2021","journal-title":"J Neurochem"},{"issue":"5796","key":"2024101807511943900_nlae054-B29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"issue":"3","key":"2024101807511943900_nlae054-B30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"issue":"Pt 9","key":"2024101807511943900_nlae054-B31","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/brain\/awh598","article-title":"The evolution and pathology of frontotemporal dementia","volume":"128","author":"Kertesz","year":"2005","journal-title":"Brain"},{"issue":"6","key":"2024101807511943900_nlae054-B32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/WCO.0b013e3283168e2d","article-title":"Selective functional, regional, and neuronal vulnerability in frontotemporal dementia","volume":"21","author":"Seeley","year":"2008","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"2024101807511943900_nlae054-B33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-018-1942-8","article-title":"Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology","volume":"137","author":"Nana","year":"2019","journal-title":"Acta Neuropathol"},{"issue":"59","key":"2024101807511943900_nlae054-B34","first-page":"1","article-title":"C9ORF72 expression and cellular localization over mouse development","volume":"3","author":"Atkinson","year":"2015","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2024101807511943900_nlae054-B35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneumeth.2012.04.020","article-title":"A comparison between different reference genes for expression studies in human hippocampal tissue","volume":"208","author":"Maurer-Morelli","year":"2012","journal-title":"J Neurosci Meth"},{"key":"2024101807511943900_nlae054-B36","volume-title":"R Development Core Team. R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2011"},{"issue":"1","key":"2024101807511943900_nlae054-B37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Soft"},{"issue":"1","key":"2024101807511943900_nlae054-B38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet Neurol"},{"issue":"10","key":"2024101807511943900_nlae054-B39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","article-title":"Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia","volume":"32","author":"Peter","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"2024101807511943900_nlae054-B40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/jamaneurol.2015.4478","article-title":"Assessment of eating behavior disturbance and associated neural networks in frontotemporal dementia","volume":"73","author":"Ahmed","year":"2016","journal-title":"JAMA Neurol"},{"issue":"3","key":"2024101807511943900_nlae054-B41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s12031-011-9547-x","article-title":"Eating disturbance in behavioural-variant frontotemporal dementia","volume":"45","author":"Piguet","year":"2011","journal-title":"J Mol Neurosci"},{"issue":"2","key":"2024101807511943900_nlae054-B42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ana.22244","article-title":"Eating and hypothalamus changes in behavioral-variant frontotemporal dementia","volume":"69","author":"Piguet","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"2024101807511943900_nlae054-B43","doi-asserted-by":"crossref","first-page":"e2465","DOI":"10.1002\/brb3.2465","article-title":"The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS)","volume":"12","author":"Ferrer-Donato","year":"2022","journal-title":"Brain Behav"},{"issue":"Pt 14","key":"2024101807511943900_nlae054-B44","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1113\/jphysiol.2009.173328","article-title":"Leptin receptor gene expression and number in the brain are regulated by leptin level and nutritional status","volume":"587","author":"Mitchell","year":"2009","journal-title":"J Physiol"},{"issue":"4","key":"2024101807511943900_nlae054-B45","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1212\/01.WNL.0000152047.58767.9D","article-title":"Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease","volume":"64","author":"Jeong","year":"2005","journal-title":"Neurology"},{"key":"2024101807511943900_nlae054-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759091419839515","article-title":"Altered brain expression of insulin and insulin-like growth factors in frontotemporal lobar degeneration: another degenerative disease linked to dysregulation of insulin metabolic pathways","volume":"11","author":"Liou","year":"2019","journal-title":"ASN Neuro"},{"issue":"8","key":"2024101807511943900_nlae054-B47","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaneurol.2015.0910","article-title":"Diabetes mellitus, obesity, and diagnosis of amyotrophic lateral sclerosis: a population-based study","volume":"72","author":"Kioumourtzoglou","year":"2015","journal-title":"JAMA Neurol"},{"issue":"1-2","key":"2024101807511943900_nlae054-B48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0169-328X(96)00081-2","article-title":"Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients","volume":"41","author":"Dor\u00e9","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"2024101807511943900_nlae054-B49","doi-asserted-by":"crossref","first-page":"840357","DOI":"10.3389\/fnins.2022.840357","article-title":"Dysregulation of translation in TDP-43 proteinopathies: deficits in the RNA supply chain and local protein production","volume":"16","author":"Bjork","year":"2022","journal-title":"Front Neurosci"},{"issue":"1","key":"2024101807511943900_nlae054-B50","doi-asserted-by":"crossref","first-page":"44461","DOI":"10.1038\/srep44461","article-title":"Calretinin and neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1G93A mouse model of ALS","volume":"7","author":"Clark","year":"2017","journal-title":"Sci Rep"},{"key":"2024101807511943900_nlae054-B51","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/brainsci11080969","article-title":"Differential NPY-Y1 receptor density in the motor cortex of ALS Patients And Familial Model of ALS","volume":"11","author":"Clark","year":"2021","journal-title":"Brain Sci"},{"issue":"1-2","key":"2024101807511943900_nlae054-B52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-3940(93)90800-Z","article-title":"Involvement of NPY-immunoreactive neurons in the cerebral cortex of amyotrophic lateral sclerosis patients","volume":"159","author":"Nihei","year":"1993","journal-title":"Neurosci Lett"},{"issue":"11","key":"2024101807511943900_nlae054-B53","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/acn3.51885","article-title":"Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice","volume":"10","author":"Clark","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"2024101807511943900_nlae054-B54","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1471-4159.2003.01670.x","article-title":"Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord","volume":"85","author":"Hu","year":"2003","journal-title":"J Neurochem"},{"key":"2024101807511943900_nlae054-B55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.brainres.2007.12.031","article-title":"Upregulation of GSK3\u03b2 expression in frontal and temporal cortex in ALS with cognitive impairment (ALSci)","volume":"1196","author":"Yang","year":"2008","journal-title":"Brain Res"},{"issue":"24","key":"2024101807511943900_nlae054-B56","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1093\/hmg\/ddr432","article-title":"Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation","volume":"20","author":"Ambegaokar","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"16","key":"2024101807511943900_nlae054-B57","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.cub.2015.06.045","article-title":"Age-dependent TDP-43-mediated motor neuron degeneration requires GSK3, hat-trick, and xmas-2","volume":"25","author":"Sreedharan","year":"2015","journal-title":"Curr Biol"},{"issue":"3","key":"2024101807511943900_nlae054-B58","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1471-4159.2004.02898.x","article-title":"Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain","volume":"92","author":"Li","year":"2005","journal-title":"J Neurochem"},{"issue":"3","key":"2024101807511943900_nlae054-B59","doi-asserted-by":"crossref","first-page":"e0151615","DOI":"10.1371\/journal.pone.0151615","article-title":"Individual case analysis of postmortem interval time on brain tissue preservation","volume":"11","author":"Blair","year":"2016","journal-title":"PLoS One"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/83\/11\/907\/59828731\/nlae054.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/83\/11\/907\/59828731\/nlae054.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T07:52:16Z","timestamp":1729237936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/83\/11\/907\/7699043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6,25]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlae054","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,6,25]]}}}